Results 71 to 80 of about 16,301 (208)
PPAR Research, 2021 Lesions caused by high glucose (HG), hypoxia/reperfusion (H/R), and the coexistence of both conditions in cardiomyocytes are linked to an overproduction of reactive oxygen species (ROS), causing irreversible damage to macromolecules in the cardiomyocyte ...
Fabiola Cortes-Lopez +12 more
doaj +1 more source
Toward Sustainable Carbonylation Reactions Enabled by CO Surrogates in Green Solvents
ChemSusChem, Volume 19, Issue 13, 14 July 2026.Carbonylation reactions offer a sustainable route to valuable carbonyl compounds. This review highlights methodologies that exploit carbonylative coupling to drastically enhance process sustainability, avoiding the direct use of CO through CO surrogates and promoting syntheses in green solvents potentially derived from renewable and sustainable sources.
Francesco Messa +2 more
wiley +1 more source
Manufacturing Nanosized Fenofibrate by Salt Assisted Milling
, 2009 Purpose: The aim of this study is to develop a new process for manufacturing a nano-sized form of the popular cholesterol-reducing drug fenofibrate which can be implemented on industrial scale with minimal changes of currently used production schemes ...
Gogotsi, Yury G. +3 more
core +1 more source
Alimentary Pharmacology &Therapeutics, Volume 64, Issue 1, Page 103-111, July 2026.In ANA‐positive patients with suspected autoimmune hepatitis (AIH), liver biopsy rarely altered therapeutic management when alanine aminotransferase (ALT) was below 101 U/L and cirrhosis was absent. These findings suggest that biopsy may be safely deferred in this low‐risk group.
David Mehdi Asgher Niazi +8 more
wiley +1 more source
Rhabdomyolysis Due to Micronized Fenofibrate
, 2010 Fenofibrate, a fibric acid derivative, is frequently used to treat diabetic dyslipidemia and hypertriglyceridemia alone or in combination with statins.
Oguzhan, Nilüfer +11 more
core +1 more source
Fenofibrate for diabetic retinopathy
, 2023 Background: Diabetic retinopathy (DR) remains a major cause of sight loss worldwide, despite new therapies and improvements in the metabolic control of people living with diabetes. Therefore, DR creates a physical and psychological burden for people, and
Kataoka, Yuki +11 more
core +1 more source
Pediatric Blood &Cancer, Volume 73, Issue 6, June 2026.ABSTRACT Background Osteonecrosis (ON) is a debilitating complication of acute lymphoblastic leukemia (ALL) therapy. While numerous studies have explored its incidence and associated risk factors, investigations using large‐scale cohorts remain important to characterize ON across heterogeneous populations.
Noémie de Villiers +5 more
wiley +1 more source
Rosiglitazone and Fenofibrate Additive Effects on Lipids
, 2011 Background. To evaluate the effect of rosiglitazone, fenofibrate, or their combined use on plasma lipids in normoglycemic healthy adults. Methods and Results.
Dorette Pearce Moore +5 more
core +1 more source
A challenging case of fenofibrate induced neutropenia
, 2022 Fenofibrate induced neutropenia is a rare condition. We reported 59-year-old male who developed neutropenia after taking fenofibrate for 20 days. He presented with complaints of fever, upper respiratory tract infection (URTI) symptoms.
Spandana Peddareddy +7 more
core +1 more source
Eruptive Xanthomas in a Patient With Severe Dyslipidemia
JEADV Clinical Practice, EarlyView.
Michał Niedźwiedź +3 more
wiley +1 more source